NCT06753591

Brief Summary

This observational multicentric national study aims to understand better acute myocardial infarction (heart attack) in young adults aged 45 years or younger in Serbia. By analyzing patient characteristics, medical history, test results, and treatment outcomes, the research seeks to identify factors contributing to heart attacks in this population and improve prevention and treatment strategies. Participants will undergo routine tests during hospitalization, and specific blood samples will be collected for advanced analyses, including genetic testing. Follow-up will include periodic check-ins to monitor health outcomes. The study will also explore differences in heart attack causes and outcomes in younger individuals compared to older populations, focusing on risk factors like smoking, cholesterol levels, and genetic predisposition. Participation is voluntary, and all collected data will remain confidential.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
4mo left

Started Sep 2024

Geographic Reach
1 country

11 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Sep 2024Sep 2026

Study Start

First participant enrolled

September 25, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 18, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 31, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 25, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 25, 2026

Last Updated

December 31, 2024

Status Verified

December 1, 2024

Enrollment Period

2 years

First QC Date

December 18, 2024

Last Update Submit

December 30, 2024

Conditions

Keywords

Acute Myocardial InfarctionPrematureYoung AdultsNational Registry

Outcome Measures

Primary Outcomes (3)

  • Incidence and Prevalence of AMI in Patients Aged ≤ 45 Years in Serbia

    The incidence and prevalence of AMI among patients aged ≤ 45 years in Serbia will be reported over the study period, expressed as the number of new and existing cases per 100,000 individuals annually Unit of Measure: "Cases per 100,000 individuals per year."

    From 01.January 2021.year to 31.December 2026.

  • Demographic Characteristics and Prevalence of Atherosclerotic Risk Factors in Young AMI Patients

    The demographic distribution (e.g., age, gender, socioeconomic status) and prevalence of standard atherosclerotic risk factors (e.g., smoking, diabetes, hypertension, hyperlipidemia) among AMI patients aged ≤ 45 years will be analyzed. Unit of Measure: "Percent of participants with each risk factor."

    From 01.January 2021.year to 31.December 2026.

  • Angiographic Characteristics in Young AMI Patients

    The presence and extent of obstructive and non-obstructive coronary artery disease, coronary lesions, dissection, and vasospasm will be assessed using angiographic findings. Unit of Measure: "Percent of participants with each angiographic characteristic."

    From 01.January 2021.year to 31.December 2026.

Secondary Outcomes (8)

  • Characteristics of Atherosclerotic Plaque Using OCT or IVUS

    From 01.January 2021.year to 31.December 2026.

  • Prevalence of SCAD in Young AMI Patients

    From 01.January 2021.year to 31.December 2026.

  • Prevalence of Comorbidities in Young AMI Patients

    From 01.January 2021.year to 31.December 2026.

  • Prevalence of Inherited or Acquired Thrombophilia in MINOCA Patients

    From 01.January 2021.year to 31.December 2026.

  • Prevalence of Familial Hypercholesterolemia in Young AMI Patients

    From 01.January 2021.year to 31.December 2026.

  • +3 more secondary outcomes

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

This national, multicentric, retrospective and prospective analysis would include patients with acute myocardial infarction (AMI) aged ≤ 45 years in Serbia

You may qualify if:

  • Patients aged ≤ 45 years. Clinical and laboratory diagnosis of acute myocardial infarction (AMI) based on the Universal Definition of Myocardial Infarction.
  • Voluntary participation with signed informed consent.

You may not qualify if:

  • Patients aged \> 45 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

Military Medical Academy 1

Belgrade, 11000, Serbia

RECRUITING

University Hospital Center Zvezdara

Belgrade, 11000, Serbia

RECRUITING

University Hospital Center Bezanijska kosa

Belgrade, 11080, Serbia

RECRUITING

University Hospital Center Zemun

Belgrade, 11080, Serbia

RECRUITING

Military Medical Academy 2

Belgrade, Serbia

RECRUITING

General Hospital Studenica

Kraljevo, 36000, Serbia

RECRUITING

University Clinical Center Nis

Niš, 18000, Serbia

RECRUITING

Institute for cardiovascular diseases Vojvodina

Novi Sad, 21000, Serbia

RECRUITING

General Hospital Prokuplje

Prokuplje, 18400, Serbia

RECRUITING

General Hospital Vrbas

Vrbas, 21460, Serbia

RECRUITING

General Hospital Zrenjanin

Zrenjanin, 23000, Serbia

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Frozen samples for the potential substudies on genetics and non-standard laboratory analysis

MeSH Terms

Conditions

Acute Coronary SyndromePremature Birth

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Aleksandra Djokovic, MD, PhD

    Cardiology Society of Serbia, Belgrade, Serbia

    PRINCIPAL INVESTIGATOR
  • Svetlana Apostolovic, Md, PhD

    Cardiology Society of Serbia, Belgrade, Serbia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Aleksandra Djokovic, MD, PhD

CONTACT

Svetlana Apostolovic, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2024

First Posted

December 31, 2024

Study Start

September 25, 2024

Primary Completion (Estimated)

September 25, 2026

Study Completion (Estimated)

September 25, 2026

Last Updated

December 31, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

For the purposes of meta statistical analysis

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
From 30.December 2026
Access Criteria
Principal Investigators of other national registries involving AIM in young adults

Locations